Connection

Julie Ann Justo to Anti-Bacterial Agents

Back to Details
This is a "connection" page, showing publications Julie Ann Justo has written about Anti-Bacterial Agents.
Julie Ann Justo
Connection Strength
3.349
Anti-Bacterial Agents
  1. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50.
    View in: PubMed
    Score: 0.371
  2. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
    View in: PubMed
    Score: 0.365
  3. Pharmacokinetics of ceftaroline in normal body weight and obese (classes I, II, and III) healthy adult subjects. Antimicrob Agents Chemother. 2015 Jul; 59(7):3956-65.
    View in: PubMed
    Score: 0.309
  4. Adverse reactions associated with systemic polymyxin therapy. Pharmacotherapy. 2015 Jan; 35(1):28-33.
    View in: PubMed
    Score: 0.297
  5. Commentary on "incidence and predictors of vancomycin-associated nephrotoxicity". South Med J. 2014 Jun; 107(6):389-90.
    View in: PubMed
    Score: 0.290
  6. Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study. Int J Antimicrob Agents. 2021 Dec; 58(6):106453.
    View in: PubMed
    Score: 0.121
  7. Use of continuous-infusion ceftolozane/tazobactam for resistant Gram-negative bacterial infections: a retrospective analysis and brief review of the literature. Int J Antimicrob Agents. 2020 Nov; 56(5):106158.
    View in: PubMed
    Score: 0.112
  8. Regional and statewide antibiograms as targeted interventions against antibiotic resistance. Infect Control Hosp Epidemiol. 2021 04; 42(4):503-505.
    View in: PubMed
    Score: 0.111
  9. Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location. Infect Control Hosp Epidemiol. 2020 08; 41(8):879-882.
    View in: PubMed
    Score: 0.110
  10. Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.
    View in: PubMed
    Score: 0.106
  11. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
    View in: PubMed
    Score: 0.104
  12. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents. Am J Infect Control. 2019 11; 47(11):1284-1289.
    View in: PubMed
    Score: 0.103
  13. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
    View in: PubMed
    Score: 0.101
  14. Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions. Clin Infect Dis. 2018 06 01; 66(12):1978-1979.
    View in: PubMed
    Score: 0.096
  15. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.
    View in: PubMed
    Score: 0.095
  16. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
    View in: PubMed
    Score: 0.089
  17. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
    View in: PubMed
    Score: 0.089
  18. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
    View in: PubMed
    Score: 0.085
  19. Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
    View in: PubMed
    Score: 0.085
  20. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
    View in: PubMed
    Score: 0.085
  21. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
    View in: PubMed
    Score: 0.082
  22. Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap. Infect Control Hosp Epidemiol. 2021 05; 42(5):622-624.
    View in: PubMed
    Score: 0.028
  23. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93.
    View in: PubMed
    Score: 0.027
  24. Preventing the Post-Antibiotic Era by Training Future Pharmacists as Antimicrobial Stewards. Am J Pharm Educ. 2018 08; 82(6):6770.
    View in: PubMed
    Score: 0.024
  25. Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection. Infection. 2018 04; 46(2):283-284.
    View in: PubMed
    Score: 0.023
  26. Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
    View in: PubMed
    Score: 0.022
  27. Staphylococcus aureus infection of the optic nerve. J Neuroophthalmol. 2015 Mar; 35(1):48-50.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.